Compare QFIN & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QFIN | PGNY |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2018 | 2019 |
| Metric | QFIN | PGNY |
|---|---|---|
| Price | $16.72 | $25.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $36.85 | $27.90 |
| AVG Volume (30 Days) | ★ 1.6M | 1.4M |
| Earning Date | 11-18-2025 | 02-26-2026 |
| Dividend Yield | ★ 9.07% | N/A |
| EPS Growth | ★ 40.93 | 2.96 |
| EPS | ★ 6.93 | 0.62 |
| Revenue | ★ $2,752,357,572.00 | $1,268,689,000.00 |
| Revenue This Year | $16.96 | $11.63 |
| Revenue Next Year | N/A | $9.52 |
| P/E Ratio | ★ $2.42 | $39.72 |
| Revenue Growth | ★ 14.06 | 11.41 |
| 52 Week Low | $16.63 | $17.98 |
| 52 Week High | $48.94 | $28.75 |
| Indicator | QFIN | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 26.37 | 48.04 |
| Support Level | $17.20 | $24.10 |
| Resistance Level | $20.27 | $28.75 |
| Average True Range (ATR) | 0.71 | 1.15 |
| MACD | -0.15 | -0.28 |
| Stochastic Oscillator | 6.97 | 27.20 |
Qfin Holdings Inc Formerly Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.